These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1706198)

  • 1. Differential effect of G-CSF and GM-CSF in acquired chronic neutropenia.
    Wodzinski MA; Hampton KK; Reilly JT
    Br J Haematol; 1991 Feb; 77(2):249-50. PubMed ID: 1706198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rational therapy with G-CSF and GM-CSF].
    Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
    Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF or GM-CSF to ameliorate chemotherapy-induced cytopenia.
    Bostrom B; Chic J
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):135-6. PubMed ID: 7680547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF and G-CSF in Felty's syndrome.
    Wagner DR; Combe C; Gresser U
    Clin Investig; 1993 Feb; 71(2):168-71. PubMed ID: 7681711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
    Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
    Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction of neutropenia with rHuG-CSF after loss of response to rHuGM-CSF following autologous bone marrow transplant.
    Boulad F; Gillio A; Small TN; Bonilla MA; Philips P; Ruggiero M; Emanuel D; Ghavimi F; Kernan NA
    Bone Marrow Transplant; 1994 May; 13(5):661-3. PubMed ID: 7519939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.
    Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Jacquy C; Burniat A; Steels E; Vallot F; Sculier JP
    Support Care Cancer; 2002 Apr; 10(3):181-8. PubMed ID: 11904782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of subcutaneous G-CSF or GM-CSF in malignancy.
    Disis ML
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 2):5-9. PubMed ID: 15934493
    [No Abstract]   [Full Text] [Related]  

  • 18. Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice.
    Ferencz T; Csaki C; Schuler D; Borsi JD
    Pediatr Hematol Oncol; 1994; 11(2):201-5. PubMed ID: 8204446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF and GM-CSF in Neutropenia.
    Mehta HM; Malandra M; Corey SJ
    J Immunol; 2015 Aug; 195(4):1341-9. PubMed ID: 26254266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.